Literature DB >> 35023380

Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling.

Charles E Seaks1,2, Erica M Weekman1,2, Tiffany L Sudduth1, Kevin Xie3, Brandi Wasek4, David W Fardo1,3, Lance A Johnson1,2, Teodoro Bottiglieri4, Donna M Wilcock1,2.   

Abstract

Vascular contributions to cognitive impairment and dementia (VCID) are the second leading cause of dementia behind Alzheimer's disease. Apolipoprotein E (ApoE) is a lipid transporting lipoprotein found within the brain and periphery. The APOE ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease and is a risk factor for VCID. Our lab has previously utilized a dietary model of hyperhomocysteinemia (HHcy) to induce VCID pathology and cognitive deficits in mice. This diet induces perivascular inflammation through cumulative oxidative damage leading to glial mediated inflammation and blood brain barrier breakdown. Here, we examine the impact of ApoE ε4 compared to ε3 alleles on the progression of VCID pathology and inflammation in our dietary model of HHcy. We report a significant resistance to HHcy induction in ε4 mice, accompanied by a number of related differences related to homocysteine (Hcy) metabolism and methylation cycle, or 1-C, metabolites. There were also significant differences in inflammatory profiles between ε3 and ε4 mice, as well as significant reduction in Serpina3n, a serine protease inhibitor associated with ApoE ε4, expression in ε4 HHcy mice relative to ε4 controls. Finally, we find evidence of pervasive sex differences within both genotypes in response to HHcy induction.

Entities:  

Keywords:  APOE; SERPIN; VCID; inflammation; metabolism

Mesh:

Substances:

Year:  2022        PMID: 35023380      PMCID: PMC9254035          DOI: 10.1177/0271678X211069006

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.960


  51 in total

Review 1.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

2.  Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.

Authors:  M Ilyas Kamboh; Ryan L Minster; Margaret Kenney; Ayla Ozturk; Purnima P Desai; Candace M Kammerer; Steven T DeKosky
Journal:  Neurobiol Aging       Date:  2005-08-30       Impact factor: 4.673

Review 3.  Homocysteine and cardiovascular disease.

Authors:  H Refsum; P M Ueland; O Nygård; S E Vollset
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

Review 4.  Alpha 1-antichymotrypsin.

Authors:  N A Kalsheker
Journal:  Int J Biochem Cell Biol       Date:  1996-09       Impact factor: 5.085

5.  An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease.

Authors:  Filippo Zappasodi; Carlo Salustri; Claudio Babiloni; Emanuele Cassetta; Claudio Del Percio; Matilde Ercolani; Paolo Maria Rossini; Rosanna Squitti
Journal:  Brain Res       Date:  2008-04-06       Impact factor: 3.252

Review 6.  Murine models of hyperhomocysteinemia and their vascular phenotypes.

Authors:  Sanjana Dayal; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-12       Impact factor: 8.311

7.  Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation.

Authors:  Maria Fe Lanfranco; Jordy Sepulveda; Gregory Kopetsky; G William Rebeck
Journal:  Glia       Date:  2021-02-08       Impact factor: 8.073

Review 8.  Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease.

Authors:  Fan Liao; Hyejin Yoon; Jungsu Kim
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

9.  β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice.

Authors:  Tiffany L Sudduth; Erica M Weekman; Holly M Brothers; Kaitlyn Braun; Donna M Wilcock
Journal:  Alzheimers Res Ther       Date:  2014-06-09       Impact factor: 6.982

10.  Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain.

Authors:  Erica M Weekman; Abigail E Woolums; Tiffany L Sudduth; Donna M Wilcock
Journal:  ASN Neuro       Date:  2017 Nov-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.